Sunshine Biopharma Inc. Foreign Currency Transaction Loss, before Tax
Sunshine Biopharma Inc. (SBFM) reported Foreign Currency Transaction Loss, before Tax of $6 for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2021-08-09
- 2021-06-30: Foreign Currency Transaction Loss, before Tax 6 month $6.00.
- 2020-06-30: Foreign Currency Transaction Loss, before Tax 6 month $8.00K.
| Period end | Foreign Currency Transaction Loss, before Tax 6 month |
|---|---|
| 2021-06-30 | $6.00 10-Q · filed 2021-08-09 |
| 2020-06-30 | $8.00K 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |